2024 US Flow Cytometry Reagents Analyzers

2024 US Flow Cytometry Reagents and Analyzers: Supplier Shares and Strategies, Technology and Instrumentation Review, Emerging Opportunities

This report contains 147 pages, 17 tables and presents a comprehensive analysis of the US flow cytometry market, including:

• Major issues pertaining to the US flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
• Five-year volume and sales forecasts for major flow cytometry tests performed in US hospitals and commercial laboratories.
• Annual placements and installed base of major flow cytometers.
• Review of current instrumentation technologies and a feature comparison of leading systems.
• Five-year reagent and instrument sales forecasts.
• Sales and market shares of leading reagent and instrument suppliers.
• Review of current and emerging diagnostic technologies, and their potential market applications.
• Product development opportunities for new instruments, consumables, and auxiliary products.
• Profiles of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and corporate strategies.
• Business opportunities and strategic recommendations for suppliers.

  Contains 174 pages and 17 tables

  This report contains 147 pages, 17 tables and presents a comprehensive analysis of the US flow cytometry market, including:
  • Major issues pertaining to the US flow cytometry practice, as well as key economic, regulatory, demographic, social and technological trends with significant market impact during the next five years.
  • Five-year volume and sales forecasts for major flow cytometry tests performed in US hospitals and commercial laboratories.
  • Annual placements and installed base of major flow cytometers.
  • Review of current instrumentation technologies and a feature comparison of leading systems.
  • Five-year reagent and instrument sales forecasts.
  • Sales and market shares of leading reagent and instrument suppliers.
  • Review of current and emerging diagnostic technologies, and their potential market applications.
  • Product development opportunities for new instruments, consumables, and auxiliary products.
  • Profiles of current and emerging suppliers, including their sales, product portfolios, marketing tactics, technological know-how, new products in R&D, collaborative arrangements, and corporate strategies.
  • Business opportunities and strategic recommendations for suppliers.

  Contains 174 pages and 17 tables

  
  
  

I. Introduction
II. Market and Technology Overview
A. Major Flow Cytometry Applications
1. Cell Surface Markers
a. Lymphocyte Subclassification CD4/CD8
Instrumentation and
Reagent Test Kits
* BD FACS Count
* Beckman Coulter VCS
* T Cells Diagnostics TRAx
b. Other Cell Markers
2. DNA Content Analysis
3. RNA Content Analysis
4. Chemotherapy Monitoring
5. Cell Cycle Analysis
6. Reticulocytes
7. Chromosome Analysis
8. Fetal Cell Analysis
9. HLA Typing
10. Microbiology
11. Protein Content Analysis
12. Multiparameter Analysis
13. Other Applications
B. Instrumentation Review
a. Introduction
b. System Overview
BD FACSadvantage
BD FACSAria III
BD FACSCalibur
BD FACScan
BD FACSCanto II
BD FACSCount
BD FACSort
BD FACStar Series
BD FACStrak

BD FACS Vantage
BD Influx
Beckman Coulter Epics C
Beckman Coulter Epics Elite Analyzer
Beckman Coulter Epics Elite ESP
Beckman Coulter Epics Profile
Beckman Coulter Epics XL
Beckman Coulter FC 500 Series
Beckman Coulter Vi-CELL XR
C. Current Market Needs and Future Demand for
Hematology Analyzers
D. Reagents and Controls
E. Current and Emerging Technologies
1. Information Technologies
2. Automation and Robotics
3. Lasers
4. Artificial Intelligence
5. Monoclonal Antibodies
6. Molecular Diagnostics
7. Microdrop Technology
III. U.S.
A. Executive Summary
B. Business Environment
1. Health Care Expenditures
2. Cost Consciousness
3. Reimbursement
4. Industry Consolidation
5. Managed Care
a. HMO
b. PPO
6. Hospitals
7. Admissions
8. Length of Stay
9. Industry Diversification
10. Physician Demographics
11. Population Aging
a. Chronic Illness
b. Disease Incidence
c. Susceptibility to Iatrogenesis
d. Multiple Illness Cases

12. Laboratory Regulations
C. Market Structure
IV. Major Product Development Opportunities
A. Instrumentation
B. Reagent Kits and Test Systems/Panels
C. Information Technology
D. Auxiliary Products
V.Design Criteria for Decentralized Testing Products
VI. Alternative Market Penetration Strategies
A. Internal Development
B. Collaborative Arrangements
C. University Contracts
D. Distribution Strategies for the Decentralized
Testing Markets
1. Four Marketing Approaches
2. Product Complexity Factor
3. Customer Preference Factor
4. Established Suppliers
5. Emerging Suppliers
6. Major Types of Distributors
7. Market Segmentation Factor
VII. Potential Market Entry Barriers and Risks
A. Market Maturity
B. Cost Containment
C. Competition
D. Technological Edge and Limitations
E. Patent Protection
F. Regulatory Constraints
G. Decentralized Testing Market Challenges

VIII. Competitive Assessments
- Abbott
- Agilent Technologies
- Beckman Coulter/Danaher
- Becton Dickinson
- Bio-Rad
- CellaVision
- Horiba
- Nihon Kohden
- Ortho-Clinical Diagnostics
- Roche
- Siemens Healthineers
- Sysmex
IX. Appendix: Major Universities and Research
Centers Developing Hematology/Flow Cytometry
Technologies and Applications

Fill The Form For Sample Request

Full Name*

Business Email *

E-mail

Country *

Select Country Albania Algeria Afghanistan Angola Argentina Armenia Aruba Australia Austria Azerbaijan Andorra Anguilla Bahrain Bangladesh Barbados Belarus Belgium Benin Bermuda Bhutan Bolivia Bosnia and Herzegovina Botswana Brazil Brunei Bulgaria Burkina Faso Burundi Bosnia Cambodia Cameroon Central African Republic Chad Chile China Colombia Comoros Congo (Brazzaville) Cook Islands Costa Rica Cote d Ivoire Croatia Cuba Cyprus Czech Republic Cayman Islands Denmark Djibouti Dominican Republic Ecuador Egypt El Salvador Equatorial Guinea Eritrea Estonia Ethiopia Fiji Finland France Gabon Gambia Georgia Germany Ghana Gibraltar Greece Guam Guatemala Guernsey Guinea Guinea-Bissau Guyana Haiti Honduras Hong Kong Hungary Herzegovina Iceland India Indonesia Iran Iraq Ireland Isle of Man Israel Italy Jamaica Japan Jersey Jordan Kazakhstan Kenya Kiribati Kuwait Korea Kyrgyzstan Laos Latvia Lebanon Lesotho Liberia Libya Lithuania Luxembourg Liechtenstein Macau Macedonia Madagascar Malawi Malaysia Maldives Mali Malta Marshall Islands Mauritania Mauritius Mexico Moldova Monaco Mongolia Montenegro Morocco Mozambique Myanmar Middle East & North Africa (MENA) Namibia Nauru Nepal Netherlands New Caledonia New Zealand Nicaragua Niger Nigeria North Korea Norway Oman Pakistan Palau Palestinian Territories Panama Papua New Guinea Paraguay Peru Philippines Poland Portugal Puerto Rico Palestine Qatar Romania Russia Rwanda Samoa Saudi Arabia Senegal Serbia Seychelles Sierra Leone Singapore Slovakia Slovenia Solomon Islands Somalia South Africa South Korea Spain Sri Lanka Saint Kitts and Nevis Saint Vincent and the Grenadines Sudan Suriname Swaziland Sweden Switzerland Syria Scotland San Marino Taiwan Tajikistan Tanzania Thailand Timor-Leste Togo Tonga Trinidad and Tobago Tunisia Turkey Turkmenistan Turks and Caicos Islands Tuvalu Uganda Ukraine United Arab Emirates United Kingdom United States of America Uruguay Uzbekistan Uraguay Vanuatu Venezuela Vietnam Virgin Islands Yemen Zambia Zimbabwe Canada Grenada Cape Verde Belize Curacao Republic of Srpska Antigua and Barbuda Saint Lucia Falkland Islands Faroe Islands Federated States of Micronesia Guadeloupe Martinique Montserrat Niue

Contact No *

Alternate No

Note : * Kindly provide us with your company id and get the sample reports at the earliest.

There is no Reviews available